NEW COMPREHENSIVE ARM AND HAND REHABILITATION THERAPY WITH THE MANOVOSPRING
24th June 2013
24th June 2013
The Swiss-based medical technology company Hocoma extends its Armeo Therapy Concept with the addon module ManovoSpring. With its adjustable hand opening support, the module assists neurological patients with impaired hand functions in efficiently practicing functional hand movements and in relearning activities of daily living. In combination with the ArmeoSpring, the module allows patients to practice reach and retrieval movements in a large 3D workspace. The simultaneous therapy of the complete movement chain from the shoulder to the fingers makes for most efficient functional rehabilitation training.
Hocoma was set up in 2000, as a spin-off of the Swiss University Hospital Balgrist. The company currently employs more than 150 people at its headquarters near Zurich, Switzerland and at its subsidiaries in the US, Singapore and Slovenia. Hocoma develops and produces therapy solutions for neurological patients with movement disorders caused by stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, cerebral palsy or other neurological diseases and injuries as well as for low back pain patients. The product range features devices for intensive locomotion therapy (Lokomat®), functional therapy of the upper extremities (Armeo®), early rehabilitation and patient mobilization (Erigo®) as well as functional movement therapy within low back pain treatment (Valedo®). Hocoma’s products are applied successfully in clinics and research institutes worldwide. This medical technology company has received many awards and was honored with the “Red Herring 100 Global Award” in January 2010, as one of the hundred most innovative companies worldwide. Hocoma generated a turnover of more than 30 million CHF in 2012. Dr. Gery Colombo is the CEO of Hocoma AG.
1. Brokaw EB, Black I, Holley RJ, Lum PS. Hand Spring Operated Movement Enhancer (HandSOME): a portable, passive hand exoskeleton for stroke rehabilitation. IEEE Tranas Neural Syst Rehabil Eng. 2011 Aug; 19(4):391-9. Epub 2011 May 27.
All Hocoma products are medical devices and must be used in strict adherence to the User Manual; failure to do so may result in serious personal injury. It is strongly recommended that you regularly consult Hocoma’s website (www.hocoma.com/legalnotes) for the latest available information. Please contact Hocoma should you have any questions.
Use only under the supervision of qualified medical personnel. However, certain Hocoma products are marketed for home use and must be strictly used according to the recommendations of your medical care provider who is knowledgeable about your specific needs. Consult the User Manual and Hocoma’s website (www.hocoma.com/legalnotes) for appropriate product designation. Failure to obtain and follow the recommendations of your medical care provider may result in serious personal injury.
This information provides details about medical products which may not be available in all countries and may not have received approval or market clearance by all governmental regulatory bodies throughout the world. Nothing herein should be construed as a solicitation or promotion of any product or of an indication of any specific use for any product which is not authorized by the laws and regulations of the country where the reader of this information resides.